Logos Global Management »

Biohaven shares owned by Logos Global Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.7M 250k 34.71
2023-03-31 $9.6M 700k 13.66

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Biohaven

Vanguard Group
BlackRock
Stifel Financial
BlackRock
Henderson Group
Suvretta Capital Management
State Street Corporation
T. Rowe Price Associates
RP Management
Farallon Capital Management
Bellevue Group
Citadel Advisors
Geode Capital Management
Point72 Asset Management
Perceptive Advisors

View all funds holding Biohaven